TAS::75 0849::TAS MULTIFUNCTIONAL NANODEVICE FOR TARGETED CANCER MR IMAGING AND
TAS::75 0849::TAS MULTIFUNCTIONAL NANODEVICE FOR TARGETED CANCER MR IMAGING AND
批准号:
8165882
负责人:
Zhiguo Zhou
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-24 至 2011-06-23
关键词:
Adverse effectsAnimalsAntineoplastic AgentsCancer Cell GrowthCancerousCell Culture TechniquesCellsDiagnosisDiagnosticDrug ControlsFoundationsGrowthImageIn VitroMagnetic Resonance ImagingMalignant NeoplasmsMicellesMonitorOutcomePatientsPharmaceutical PreparationsPhaseSiteTestingTherapeuticTherapeutic Indexdesigndrug efficacyimprovedin vivoinnovationnanodeviceprematurepreventresearch and developmentresearch studytargeted deliverytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Multifunctional theranostic nanodevices carrying therapeutic payloads, diagnostic agents, and targeted and controlled drug release functions can simultaneously and effectively diagnose and treat cancers. The
targeted delivery of chemotherapeutics to tumors can significantly increase the efficacy of drugs while minimizing the severe side effects associated with the drug itself. The integration of the four functions into
one single platform holds great promise for increasing therapeutic index and improving patient outcome. The proposed theranostic nanodevice by Luna Innovations will be tested in both cell culture experiments and
in vivo small animal studies during the Phase I period. Each component of the integrated nanodevice has been designed to carry its specific function of loading anticancer drugs, preventing the drug from premature
release, triggering drug release when it reaches its intended region of action, guiding the nanodevice to tumor sites, inhibiting the growth of cancerous cells, or monitoring the tumor regression by MR imaging. Luna anticipates that both of the in vitro and in vivo results will validate the design of the multifunctional nanodevice and demonstrate the feasibility of the nanodevice for simultaneous diagnosis and treatment of tumors. These results will provide a foundation for full R&D efforts in Phase II.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fullerene-based Radioprotectors for Use during Brain Radiotherapy, Period of Performance 09/15/2014 - 05/15/2015
-
批准号:8948732
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2014
-
负责人:Zhiguo Zhou
-
依托单位:
Developing New Assessment Tools for Carbon Nanomaterial-Based Contaminants
-
批准号:8714259
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Zhiguo Zhou
-
依托单位:
Nanoparticle scavengers for in vivo sequestration of overdosed drug molecules
-
批准号:8524099
-
项目类别:
-
资助金额:$12.84万
-
财政年份:2013
-
负责人:Zhiguo Zhou
-
依托单位:
Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis
-
批准号:8686795
-
项目类别:
-
资助金额:$71.09万
-
财政年份:2013
-
负责人:Zhiguo Zhou
-
依托单位:
Nanoparticle scavengers for medical countermeasures against mycotoxin
-
批准号:8524115
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2013
-
负责人:Zhiguo Zhou
-
依托单位:
Enhanced bioscavenger for medical countermeasures against organophosphorus agents
-
批准号:8524618
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2013
-
负责人:Zhiguo Zhou
-
依托单位:
Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis
-
批准号:8507969
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2013
-
负责人:Zhiguo Zhou
-
依托单位:
海外基金